The Prostate Health Index: a new test for the detection of prostate cancer.
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesContemporary Management of Prostate CancerAll-printed highly sensitive 2D MoS2 based multi-reagent immunosensor for smartphone based point-of-care diagnosis.Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)A genetic-based approach to personalized prostate cancer screening and treatment.Serum markers in prostate cancer detectionProstate cancer marker panel with single cell sensitivity in urine.Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonographyBiomarkers in prostate cancer: new era and prospective.Prostate-specific antigen screening, why have the guidelines changed?Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.Expectant management for men with early stage prostate cancer.Malakoplakia of the Prostate as a Mimicker of Prostate Cancer on Prostate Health Index and Magnetic Resonance Imaging-Fusion Prostate Biopsy: A Case Report.A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.A urologist's perspective on prostate cancer imaging: past, present, and future.ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.Risk stratification of prostate cancer 2016.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.Editorial: Prostate Cancer: What We Know and What We Would Like to Know.Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia.Lymph node imaging in initial staging of prostate cancer: An overview and update.Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer.Zinc as an Imaging Biomarker of Prostate Cancer
P2860
Q26749401-289D9ED0-E000-4E96-88BA-4617028D7F32Q26767456-1A845BC4-FFBC-457E-91F9-F3AECBC9BCEBQ33455695-74A54E81-FE5C-4E25-A8E5-65F908DEADA7Q33567004-A492ED4D-B75E-4191-B80C-0FB0ED71694DQ33838513-DD78F056-CDD4-41A3-BCD6-70160AD31646Q34802764-B48F9906-3BD0-423F-BF04-5E67CC00AD4FQ35042519-78B54383-C14E-4861-A435-277E39F973DEQ35582373-E68E80C5-6DF2-4215-A2F1-44372720D82BQ37113204-86F7ADA0-4225-4629-9E56-D1CAE026D1F9Q38232466-1CBC3737-FA02-4A97-BD45-928CFB3B4B68Q38259244-469CC88E-EDAA-457D-95A8-964409AFC9C9Q38461592-85EFC587-9446-41A1-BF6F-19F3513B1A34Q38469754-F0F497B1-DC95-441A-898E-F0F84107BAF8Q38665504-165D75BE-2F3E-433F-8DA4-1A9C760FA7FBQ38725930-3CA6A9F4-ED02-4472-98FA-DC0D0904F5D5Q38734333-F5091AC7-5258-480B-B42E-599A7554AF56Q38741968-91266D74-ADA7-4058-AF01-E1A86AF0C6FCQ38762709-9ED11798-DBB5-4FCC-8551-53C8FC44F192Q38786630-62CD43A4-BA7F-489D-B590-92E70C37B4B3Q38823661-B0D4BBE1-8506-4DAF-95FD-27D75E6CB562Q38891544-F334BA89-4B57-455F-AB35-186C8B5FB6C7Q38929868-FF2916B3-4C0B-4225-BBE0-8C3234E8421BQ39243268-14F05133-77B9-4071-B2A8-67206CACA1CCQ40237929-30F27E40-E643-48B5-AAAB-75F0EC2539ADQ40955296-00DB635E-6FAD-49D3-A483-3C09D2062AD5Q47098249-37A6D3DE-886F-40FE-8B85-4A6E0D104F66Q47157403-EEDEE4F9-23E4-431D-BE07-4C62C5907DBAQ48225109-6289FEF8-5B74-455C-9D02-3D40F6D12CF9Q49683786-DA676680-9EDD-4EED-A089-4AEF0E729DBEQ55025747-40966C5E-A60B-43EF-A000-43DB85F0E79DQ57498737-1ADB3371-57C6-4317-B92A-867224B079E0
P2860
The Prostate Health Index: a new test for the detection of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Prostate Health Index: a new test for the detection of prostate cancer.
@en
The Prostate Health Index: a new test for the detection of prostate cancer.
@nl
type
label
The Prostate Health Index: a new test for the detection of prostate cancer.
@en
The Prostate Health Index: a new test for the detection of prostate cancer.
@nl
prefLabel
The Prostate Health Index: a new test for the detection of prostate cancer.
@en
The Prostate Health Index: a new test for the detection of prostate cancer.
@nl
P2860
P356
P1476
The Prostate Health Index: a new test for the detection of prostate cancer.
@en
P2093
William J Catalona
P2860
P356
10.1177/1756287213513488
P50
P577
2014-04-01T00:00:00Z